Hinge Health Inc. (NYSE:HNGE - Get Free Report) President James Pursley sold 33,000 shares of the business's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $88.05, for a total value of $2,905,650.00. Following the transaction, the president directly owned 706,235 shares of the company's stock, valued at approximately $62,183,991.75. The trade was a 4.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
James Pursley also recently made the following trade(s):
- On Monday, June 22nd, James Pursley sold 33,000 shares of Hinge Health stock. The shares were sold at an average price of $69.31, for a total transaction of $2,287,230.00.
- On Tuesday, May 26th, James Pursley sold 16,000 shares of Hinge Health stock. The shares were sold at an average price of $53.79, for a total transaction of $860,640.00.
Hinge Health Trading Up 1.5%
Shares of Hinge Health stock opened at $89.78 on Tuesday. The firm's 50 day moving average is $81.82 and its 200 day moving average is $58.85. The firm has a market capitalization of $7.24 billion, a PE ratio of 70.15 and a beta of 1.31. Hinge Health Inc. has a 1 year low of $30.08 and a 1 year high of $93.13.
Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.28 by $0.31. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The business had revenue of $212.82 million during the quarter. During the same period in the previous year, the company earned $0.59 EPS. Hinge Health's revenue for the quarter was up 53.0% on a year-over-year basis. As a group, research analysts anticipate that Hinge Health Inc. will post 1.25 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on HNGE. Weiss Ratings reissued a "sell (d-)" rating on shares of Hinge Health in a report on Monday, August 3rd. Royal Bank Of Canada upped their target price on Hinge Health from $75.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. Truist Financial increased their target price on Hinge Health from $85.00 to $112.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Piper Sandler restated an "overweight" rating on shares of Hinge Health in a report on Wednesday, June 10th. Finally, Morgan Stanley upped their price objective on Hinge Health from $72.00 to $108.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Hinge Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $100.57.
Get Our Latest Research Report on Hinge Health
Institutional Investors Weigh In On Hinge Health
Institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN increased its stake in shares of Hinge Health by 160.0% in the fourth quarter. Wells Fargo & Company MN now owns 546 shares of the company's stock valued at $25,000 after buying an additional 336 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health during the 4th quarter valued at approximately $26,000. Nykredit A S acquired a new stake in Hinge Health during the 2nd quarter valued at approximately $29,000. CENTRAL TRUST Co bought a new position in Hinge Health during the 1st quarter worth approximately $37,000. Finally, High Point Wealth Management LLC bought a new position in Hinge Health during the 4th quarter worth approximately $46,000.
About Hinge Health
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
